Rapid Communications in Mass Spectrometry · 2017 · 11 citations · 11 references
PharmacyPharmacologyToxicologyChromatographic AnalysisDrug MetabolismPharmaceutical ToxicologyChromatographyDegradation Product AnalysisDegradation ProductsForced Degradation StudiesLiquid ChromatographyPharmaceutical StabilityAnalytical Liquid ChromatographyCompound Degradation ProfilingDegradation Product AssessmentIn Silico Toxicity PredictionTandem Mass SpectrometryTandem Mass Spectrometry AnalysisTherapeutic Benefit-risk AssessmentToxicity Of Degradation Products
RATIONALE: Forced degradation studies are useful for better understanding of the stability of active pharmaceutical ingredients and drugs and to generate information about drug degradation pathways and formation of degradation products (DPs). Identification of DPs plays a vital role in establishing the safety and therapeutic benefit of a drug. METHODS: (100 × 2.1 mm, 1.7 μm) column using acetonitrile-methanol (70:30, v/v) and formic acid in gradient mode. The same UPLC method was employed for LC/HRMS for the characterization of DPs. In addition, in silico toxicity was predicted for all the DPs by using TOPKAT and DEREK software tools. RESULTS: CAN was found to degrade under oxidative stress condition and formed DP1 and DP2. This is a typical case of degradation where co-solvents acetonitrile-water (50:50, v/v) and methanol-water (50:50, v/v) react with CAN under acid hydrolytic conditions leading to the formation of pseudo-DPs, DP3 and DP4, respectively. Among these, DP2 and DP3 showed ocular irritancy whereas DP1 showed skin sensitization. CONCLUSIONS: The drug was labile under oxidative stress condition. CAN reacted with co-solvent under acid hydrolytic conditions and gave pseudo-DPs. All the DPs were separated using UPLC and characterized by LC/QTOF/MS/MS. Toxicity of DPs was evaluated using TOPKAT and DEREK software tools.
11
Diagnosis and Classification of Diabetes Mellitus
Diabetes Care · 2006 · 928 citations · Full text
Sue Sha, Damayanthi Devineni, A. Ghosh et al. · Diabetes Obesity and Metabolism · 2011 · 294 citations
Damayanthi Devineni, Christopher R. Curtin, David Polidori et al. · The Journal of Clinical Pharmacology · 2013 · 216 citations
Ronald D. Snyder, Greg S. Pearl, George Mandakas et al. · Environmental and Molecular Mutagenesis · 2004 · 139 citations